Palonosetron Hydrochloride Patent Expiration
Palonosetron Hydrochloride is Used for preventing nausea and vomiting caused by chemotherapy and postoperative procedures. It was first introduced by Helsinn Healthcare Sa
Palonosetron Hydrochloride Patents
Given below is the list of patents protecting Palonosetron Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Aloxi |
US7947724 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US7947725 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US7960424 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US8518981 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US8598218 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US8598219 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US8729094 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US9066980 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US9125905 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US9173942 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US9439854 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US9457020 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US9457021 (Pediatric) | Liquid pharmaceutical formulations of palonosetron |
Jul 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US7947724 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US7947725 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US7960424 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US8518981 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US8598218 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US8598219 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US8729094 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US9066980 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US9125905 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US9173942 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US9439854 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US9457020 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi | US9457021 | Liquid pharmaceutical formulations of palonosetron |
Jan 30, 2024
(Expired) | Helsinn Hlthcare |
| Aloxi |
US5202333 (Pediatric) | Tricyclic 5-HT3 receptor antagonists |
Oct 13, 2015
(Expired) | Helsinn Hlthcare |
| Aloxi | US5202333 | Tricyclic 5-HT3 receptor antagonists |
Apr 13, 2015
(Expired) | Helsinn Hlthcare |
Palonosetron Hydrochloride's Family Patents
